Clinicalpathological features | SC/ASC (n = 46) | AC (n = 80) | χ2 | P |
---|---|---|---|---|
Gender | Â | Â | Â | Â |
male | 19(41.3) | 26(32.5) | 0.986 | 0.352 |
female | 27(58.7) | 54(67.5) | ||
Age (years) | Â | Â | Â | Â |
≤ 45 | 3(6.5) | 16(20.0) | 4.143 | 0.042 |
> 45 | 43(93.5) | 64(80.0) | ||
Degree of differentiation | Â | Â | Â | Â |
well-differentiated | 16(34.8) | 27(33.8) | 8.515 | 0.014 |
moderately-Differentiated | 24(52.2) | 25(31.3) | ||
poorly-differentiated | 6(13.0) | 28(35.0) | ||
Tumor maximum diameter (cm) | Â | Â | Â | Â |
≤ 3 cm | 20(43.5) | 50(62.5) | 4.280 | 0.039 |
> 3 cm | 26(56.5) | 30(37.5) | Â | Â |
Gallbladder stones | Â | Â | Â | Â |
no | 18(39.1) | 42(52.5) | 2.093 | 0.148 |
yes | 28(60.9) | 38(47.5) | ||
TNM stage | Â | Â | Â | Â |
I+II | 12(26.1) | 21(26.3) | 0.287 | 0.866 |
III | 20(33.5) | 38(47.5) | ||
IV | 14(30.4) | 21(26.3) | ||
Lymph node metastasis | Â | Â | Â | Â |
no | 17(37.0) | 30(37.5) | 0.004 | 0.952 |
yes | 29(63.0) | 50(62.5) | Â | Â |
Invasion | Â | Â | Â | Â |
no | 16(34.8) | 31(38.8) | 0.197 | 0.658 |
yes | 30(62.5) | 49(61.3) | ||
Surgical | Â | Â | Â | Â |
radical | 14(30.4) | 26(32.5) | 0.215 | 0.898 |
palliative | 18(39.1) | 28(35.0) | ||
biopsy | 14(30.4) | 26(32.5) | ||
average survival time | 10.07(4 to 25) | 10.34(3 to 27) | 0.014 | 0.906 |
CCT2 | Â | Â | Â | Â |
- | 23(50.0) | 31(46.2) | 0.165 | 0.685 |
+ | 23(50.0) | 49(53.8) | Â | Â |
PDIA3 | Â | Â | Â | Â |
- | 20(43.5) | 35(43.7) | 0.001 | 0.976 |
+ | 26(56.5) | 45(56.3) | Â | Â |